Table 4.
Metabolic and Blood Pressure Control Compared Between Those with No DR and Those with DR, Between Those with No DR and Those with NPDR, and Between Those with No DR and Those with PDR
| Parameters | No DR (N = 737) | DR (N = 393) | p-value* | NPDR (N = 301) | p-value** | PDR (N = 92) | p-value*** |
|---|---|---|---|---|---|---|---|
| SBP >140 mmHg | 226 (30.7%) | 160 (40.7%) | 0.001 | 122 (40.5%) | 0.002 | 38 (41.3%) | 0.039 |
| DBP >90 mmHg | 72 (9.8%) | 32 (8.1%) | 0.389 | 26 (8.6%) | 0.729 | 6 (6.5%) | 0.452 |
| FPG ≥130 mg/dL | 442 (60.0%) | 231 (58.8%) | 0.703 | 182 (60.5%) | 0.732 | 49 (53.3%) | 0.223 |
| HbA1c >7% | 393 (53.3%) | 278 (70.7%) | <0.001 | 215 (71.4%) | <0.001 | 63 (68.5%) | 0.076 |
| TC ≥200 mg/dL | 88 (11.9%) | 45 (11.5%) | 0.847 | 36 (12.0%) | 0.917 | 9 (9.8%) | 0.616 |
| TG ≥150 mg/dL | 230 (31.2%) | 112 (28.5%) | 0.377 | 85 (28.2%) | 0.381 | 27 (29.3%) | 0.906 |
| LDL-C ≥100 mg/dL | 238 (32.3%) | 120 (30.5%) | 0.591 | 87 (28.9%) | 0.247 | 33 (35.9%) | 0.413 |
| HDL-C <40 mg/dL | 180 (24.4%) | 119 (30.3%) | 0.050 | 90 (29.9%) | 0.170 | 29 (31.5%) | 0.267 |
Notes: Data were reported in number (percentage). * p-value when No DR was compared with DR. ** p-value when No DR was compared with NPDR. *** p-value when No DR was compared with PDR.
Abbreviations: DR, diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.